Suven Pharmaceuticals Ltd, based in India, is a pharmaceutical company that stands out with its certifications from EDQM.
One of their notable products is FENOPROFEN CALCIUM USP, with a corresponding US DMF Number 20498.
Remarkably, this DMF maintains an Active status since its submission on April 26, 2007, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 29, 2019, and payment made on September 27, 2019, indicating their dedication to facilitating drug approvals, Categorized as Type II